Stephen Dewhurst, PhD
Vice President for Research, University of Rochester Medical Center, and Vice Dean for
Research, School of Medicine & Dentistry
Stephen Dewhurst is Vice President for Research at the University of Rochester (UR), Vice Dean for Research at the UR’s School of Medicine & Dentistry (SMD), and a Professor of Microbiology and Immunology at the UR School of Medicine & Dentistry. Steve has over 30 years of experience in virology research, with current interests that include: (1) Understanding the interaction of
HIV with glial cells; (2) Developing an improved live attenuated influenza vaccine (LAIV); (3) Elucidating the host cell response to infection by viral pathogens (with emphasis on SARS-CoV-2). He is the Co-Director of the UR’s NIH-funded Clinical Trials Unit (which conducts
clinical trials of novel vaccines and therapeutics for HIV/AIDS, and currently also for COVID-19). His recent past roles include: NIH study section member and chair; director of the UR’s Cell Therapy Manufacturing Facility; President of a UR vaccine startup company (Codevax).
